Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo.

Abstract

RB 90740 is the lead compound in a series of aromatic mono-N-oxide bioreductive drugs. The compound shows considerably greater toxicity towards hypoxic verses aerobic mammalian cells in vitro. The differential in concentration required to give the same level of cell killing under these conditions ranges from 3.5 in a human bronchio-alveolar tumor cell line up to 120 in a rodent cell line defective in the repair of DNA strand breaks. The ability of RB 90740 to cause DNA strand breaks under hypoxic conditions was confirmed by alkaline sucrose gradient and pulsed field gel electrophoresis techniques. Despite these properties demonstrated in vitro, RB 90740 was shown not to be cytotoxic to hypoxic cells in experimental murine tumors in vivo. This may be due, in part, to the level of hypoxia (< 0.02% O2) necessary to produce toxicity in vitro.

• Authors: M A Naylor, G E Adams, A Haigh, S Cole, T Jenner, N Robertson, D Siemann, M A Stephens, I J Stratford
• Journal: Anti-cancer drugs (Anticancer Drugs) Vol. 6 Issue 2 Pg. 259-69 (Apr 1995) ISSN: 0959-4973 [Print] England
• PMID: 7795274 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Antineoplastic Agents
• Pyrazines
• RB 90740

Topics

• Animals
• Antineoplastic Agents (pharmacology)
• Cell Survival (drug effects)
• Cricetinae
• DNA Damage
• Female
• Male
• Mice
• Mice, Inbred C3H
• Neoplasms, Experimental (drug therapy)
• Pyrazines (pharmacology)
• Tumor Cells, Cultured